DNA Methylation in Barrett's Esophagus and Esophageal Adenocarcinoma
Author Information
Author(s): Eric Smith, Neville J De Young, Sandra J Pavey, Nick Hayward, Derek J Nancarrow, David C Whiteman, B Mark Smithers, Andrew R Ruszkiewicz, Andrew D Clouston, David C Gotley, Peter G Devitt, Glyn G Jamieson, Paul A Drew
Primary Institution: The University of Adelaide
Hypothesis
At what stage in the progression from Barrett's esophagus to esophageal adenocarcinoma does methylation of key genes occur?
Conclusion
Significant methylation occurs in metaplastic Barrett's esophagus, which is similar to that found in esophageal adenocarcinoma for most genes studied.
Supporting Evidence
- Nine genes were examined for methylation in Barrett's esophagus and esophageal adenocarcinoma.
- Significant differences in methylation frequency were found between cancerous and non-cancerous tissues.
- Seven of the nine genes showed similar methylation frequencies in Barrett's esophagus and esophageal adenocarcinoma.
Takeaway
This study shows that Barrett's esophagus is more like cancer tissue than normal tissue because it has a lot of changes in its DNA that can turn off important genes.
Methodology
The study examined the methylation of nine genes in tissue samples from patients with Barrett's esophagus and esophageal adenocarcinoma using bisulfite modified DNA analysis.
Potential Biases
Potential bias in sample selection as tissues were obtained from different patients.
Limitations
The study did not include longitudinal data to track methylation changes over time.
Participant Demographics
The study included 38 patients with esophageal adenocarcinoma, 18 patients with Barrett's esophagus, and 7 patients without Barrett's or EAC.
Statistical Information
P-Value
0.0104 for CDKN2A and 0.0358 for RUNX3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website